drugset / Trial / NCT01509261

Efficacy Study of Ilaprazole to Treat Erosive Esophgitis

NCT01509261

Phase 3 Completed 292 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

This study compared Ilaprazole 20mg with lansoprazole 30mg for the healing of erosive esophagitis and resolution of heartburn.

Timeline

Start
2010-07
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ilaprazole Small molecule 20 mg
Comparator Lansoprazole Other / unclassified 30 mg